FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Expires:December 31, 2014
Estimated average burden
hours per response0.5
1. Name and Address of Reporting Person*
Giffoni Kim

(Last)(First)(Middle)
C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301

(Street)
LOS ANGELESCA90077

(City)(State)(Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/31/2011
3. Issuer Name and Ticker or Trading Symbol
Targeted Medical Pharma, Inc. [NONE]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
EVP Foreign Sales/Inv. Rel.
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 3,292,736
I
By Giffoni Family Trust Dated September 26, 2008 (1) (2)
Common Stock 53,241
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)4. Conversion or Excercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This Form 3 is filed jointly by Kim Giffoni, Olena B. Giffoni and the Giffoni Family Trust Dated September 26, 2008 ("Giffoni Family Trust"). The Giffoni Family Trust is a 10% owner of the Company and Mr. Giffoni and Ms. Giffoni may be deemed to be 10% owners of the Company. Mr. Giffoni is the Executive Vice President of Foreign Sales and Investor Relations and a director of the Company.
2. These securities are owned indirectly by Mr. Giffoni and Ms. Giffoni by virtue of their being co-Trustees of the Giffoni Family Trust. Mr. Giffoni and Ms. Giffoni share voting and dispositive control with respect to the securities owned by the Giffoni Family Trust. Mr. Giffoni and Ms. Giffoni disclaim beneficial ownership of any shares owned by the Giffoni Family Trust except to the extent of their pecuniary interest therein.
Giffoni Family Trust dated September 26, 2008, by /s/ Kim Giffoni, Co-Trustee01/31/2011
** Signature of Reporting PersonDate
/s/ Kim Giffoni01/31/2011
** Signature of Reporting PersonDate
/s/ Olena B. Giffoni01/31/2011
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.